Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a founder BRCA1 mutation in the Moroccan population.

Clinical genetics - 1 Oct 2016

Quiles F, Teulé À, Martinussen Tandstad N, Feliubadaló L, Tornero E, Del Valle J, Menéndez M, Salinas M, Wethe Rognlien V, Velasco A, Izquierdo A, Capellá G, Brunet J, Lázaro C

Abstract excerpt

Breast cancer (BC) is the most frequent cancer among women in Morocco. However, the role of the most prevalent BC-predisposing genes, BRCA1 and BRCA2, has been largely unexplored. To help define the role of BRCA1 in BC in Morocco, we characterized the first potential BRCA1 founder mutation in this population. Genetic testing of BRCA1 and BRCA2 in BC high-risk families identified mutation BRCA1 c.5309G>T,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to Founder Effect

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Haplotypes

Share to Microsatellite Repeats

Share to Morocco

Share to Mutation

Share to Pedigree

Source

Identifiers

PMID: 26864382
DOI: 10.1111/cge.12747

Genes

BRCA1
BRCA2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a founder BRCA1 mutation in the Moroccan population.PMID 26864382Read ↗

Mutation screening of the BRCA1 gene in early onset and familial breast/ovarian cancer in Moroccan population.Semantic proximity Read ↗

Mutational spectrum of BRCA1/2 genes in Moroccan patients with hereditary breast and/or ovarian cancer, and review of BRCA mutations in the MENA region.Semantic proximity Read ↗

High frequency of the recurrent c.1310_1313delAAGA BRCA2 mutation in the North-East of Morocco and implication for hereditary breast-ovarian cancer prevention and control.Semantic proximity Read ↗

Specific BRCA1 gene variations amongst young Moroccan breast cancer patients.Semantic proximity Read ↗

BRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North African.Semantic proximity Read ↗

Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.Semantic proximity Read ↗

BRCA1 and BRCA2 germline variants in breast cancer patients from the Republic of Macedonia.Semantic proximity Read ↗

Complete mutation screening and haplotype characterization of BRCA1 gene in Tunisian patients with familial breast cancer.Semantic proximity Read ↗

Contribution of BRCA1 and BRCA2 germline mutations to early onset breast cancer: a series from north of Morocco.Semantic proximity Read ↗

BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: Novel mutations and unclassified variantsSemantic proximity Read ↗

Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population.Semantic proximity Read ↗

Increased prevalence of the founder BRCA1 c.5309G>T and recurrent BRCA2 c.1310_1313delAAGA mutations in breast cancer families from Northerstern region of Morocco: evidence of geographical specificity and high relevance for genetic counseling.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.